WO2001016090A1 - Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto - Google Patents
Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto Download PDFInfo
- Publication number
- WO2001016090A1 WO2001016090A1 PCT/US2000/024347 US0024347W WO0116090A1 WO 2001016090 A1 WO2001016090 A1 WO 2001016090A1 US 0024347 W US0024347 W US 0024347W WO 0116090 A1 WO0116090 A1 WO 0116090A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound
- mass
- daltons
- hydrogen
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 119
- 238000000034 method Methods 0.000 title claims description 34
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 45
- 239000001257 hydrogen Substances 0.000 claims abstract description 45
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 33
- 150000002367 halogens Chemical group 0.000 claims abstract description 29
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 125000004429 atom Chemical group 0.000 claims abstract description 9
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 5
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 5
- 150000002431 hydrogen Chemical class 0.000 claims abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 32
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 30
- 229910052757 nitrogen Inorganic materials 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 20
- 229910052760 oxygen Inorganic materials 0.000 claims description 16
- 229910052717 sulfur Inorganic materials 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 12
- 239000001301 oxygen Substances 0.000 claims description 12
- 239000011593 sulfur Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 10
- 150000001412 amines Chemical class 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 9
- 150000001408 amides Chemical class 0.000 claims description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- 239000012620 biological material Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 238000005984 hydrogenation reaction Methods 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- 125000006239 protecting group Chemical group 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 4
- 239000002262 Schiff base Substances 0.000 claims description 4
- 150000004753 Schiff bases Chemical class 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 150000008300 phosphoramidites Chemical class 0.000 claims description 4
- 125000004437 phosphorous atom Chemical group 0.000 claims description 4
- 239000011574 phosphorus Substances 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 3
- 229930195733 hydrocarbon Natural products 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 2
- 108091005461 Nucleic proteins Proteins 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims description 2
- GNVMUORYQLCPJZ-UHFFFAOYSA-M Thiocarbamate Chemical compound NC([S-])=O GNVMUORYQLCPJZ-UHFFFAOYSA-M 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 239000011203 carbon fibre reinforced carbon Chemical group 0.000 claims description 2
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical group NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000000524 functional group Chemical group 0.000 claims description 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 2
- 150000007857 hydrazones Chemical group 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- 150000002466 imines Chemical group 0.000 claims description 2
- 150000002923 oximes Chemical group 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical group [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Chemical group 0.000 claims description 2
- 125000005541 phosphonamide group Chemical group 0.000 claims description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical group [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 2
- SXADIBFZNXBEGI-UHFFFAOYSA-N phosphoramidous acid Chemical group NP(O)O SXADIBFZNXBEGI-UHFFFAOYSA-N 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 2
- 229940124530 sulfonamide Drugs 0.000 claims description 2
- 150000003456 sulfonamides Chemical group 0.000 claims description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical group [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 2
- 150000007970 thio esters Chemical class 0.000 claims description 2
- 150000003568 thioethers Chemical class 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 8
- -1 2-nitrophenyl group Chemical group 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000011914 asymmetric synthesis Methods 0.000 description 6
- 125000004494 ethyl ester group Chemical group 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 239000004472 Lysine Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 4
- 150000001721 carbon Chemical group 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- SJWDOSCKIYWKEW-UHFFFAOYSA-N methyl 3-amino-3-(2-nitrophenyl)propanoate Chemical compound COC(=O)CC(N)C1=CC=CC=C1[N+]([O-])=O SJWDOSCKIYWKEW-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000004313 potentiometry Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- KPWKPGFLZGMMFX-VHSXEESVSA-N (-)-camphanic acid Chemical compound C1C[C@]2(C(O)=O)OC(=O)[C@@]1(C)C2(C)C KPWKPGFLZGMMFX-VHSXEESVSA-N 0.000 description 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 2
- XXBOYULKNZTOMN-UHFFFAOYSA-N 3-azaniumyl-3-(2-nitrophenyl)propanoate Chemical compound OC(=O)CC(N)C1=CC=CC=C1[N+]([O-])=O XXBOYULKNZTOMN-UHFFFAOYSA-N 0.000 description 2
- 0 CC(C)(*)C(*)C1=CC=C*(*2CC2)C=C1[N+]([O-])=O Chemical compound CC(C)(*)C(*)C1=CC=C*(*2CC2)C=C1[N+]([O-])=O 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000007821 HATU Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- SRJOCJYGOFTFLH-UHFFFAOYSA-N isonipecotic acid Chemical compound OC(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- VCQURUZYYSOUHP-UHFFFAOYSA-N (2,3,4,5,6-pentafluorophenyl) 2,2,2-trifluoroacetate Chemical compound FC1=C(F)C(F)=C(OC(=O)C(F)(F)F)C(F)=C1F VCQURUZYYSOUHP-UHFFFAOYSA-N 0.000 description 1
- CAPMCEBUZGWMBU-UHFFFAOYSA-N (2,3,4,5-tetrafluorophenyl) 2,2,2-trifluoroacetate Chemical compound FC1=CC(OC(=O)C(F)(F)F)=C(F)C(F)=C1F CAPMCEBUZGWMBU-UHFFFAOYSA-N 0.000 description 1
- JIDDDPVQQUHACU-YFKPBYRVSA-N (2s)-pyrrolidine-2-carbaldehyde Chemical group O=C[C@@H]1CCCN1 JIDDDPVQQUHACU-YFKPBYRVSA-N 0.000 description 1
- CMIBUZBMZCBCAT-HOTGVXAUSA-N (2s,3s)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid Chemical compound C1=CC(C)=CC=C1C(=O)O[C@H](C(O)=O)[C@@H](C(O)=O)OC(=O)C1=CC=C(C)C=C1 CMIBUZBMZCBCAT-HOTGVXAUSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- HCKNAJXCHMACDN-UHFFFAOYSA-N 1-methylpiperidine-4-carboxylic acid Chemical compound CN1CCC(C(O)=O)CC1 HCKNAJXCHMACDN-UHFFFAOYSA-N 0.000 description 1
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 238000004082 amperometric method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 125000000837 carbohydrate group Chemical group 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 108010062049 chirobiotic T Proteins 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125890 compound Ia Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 125000001905 inorganic group Chemical group 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003667 tyrosine derivatives Chemical class 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B70/00—Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/141—Esters of phosphorous acids
- C07F9/1414—Esters of phosphorous acids with arylalkanols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2404—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2429—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of arylalkanols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
- C12P41/007—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving acyl derivatives of racemic amines
Definitions
- the present invention relates generally to enantiomerically-enriched compounds, specifically enantiomerically-enriched compounds having one or more photocleavable bonds, as well as methods relating thereto, including synthetic methods.
- CMSTs cleavable mass spectrometry tags
- SNP single nucleotide polymorphism
- the present invention provides advantageous tags, including tags detectable by mass spectrometry, and methods of their use, as disclosed more fully herein.
- the present invention affords enantiomerically-enriched compounds having photocleavable bonds, and methods for preparing labeled molecules with enantiomerically-enriched photocleavable tags.
- the present invention provides advantages including the ability to obtain a single distinct product in those instances where there is a need to isolate members of a plurality of structurally similar tagged molecules, as well as further related advantages as disclosed more fully herein.
- the present invention provides a compound having the formula (I) or (II):
- R 1 is selected from halogen and organic moieties
- R 2 and R are independently selected from hydrogen and organic moieties having a mass greater than 15 Daltons where R and R can together form a carbonyl group or may be joined together within a cyclic structure
- Z is an (n+l)-valent atom excluding carbon where n is an integer greater than 0
- R is independently selected from hydrogen, halogen, and organic moieties having a mass greater than 15 Daltons, with the proviso that at least one R 4 (namely R 4a ) is an organic moiety having a mass greater than 100 Daltons
- R 5 at each occurrence is independently either halogen or an organic moiety having a mass of less than 500 Daltons
- Z is nitrogen; R 4a is detectable by mass spectrometry; R 2 and R 3 are each hydrogen; R 1 comprises synthetic or natural biological material (e.g., nucleic acid, protein or saccharide); and/or R 4a has a mass of less than 10,000 Daltons and a molecular formula of C
- R 4a is detectable by mass spectrometry
- R 2 and R 3 are each hydrogen
- R 1 comprises synthetic or natural biological material (e.g., nucleic acid, protein or saccharide); and/or R 4a has a mass of less than 10,000 Daltons and a molecular formula of C
- R 4a has the formula T 2 -(J-T 3 -) P -; wherein T 2 is an organic moiety formed from carbon and one or more of hydrogen, fluoride, iodide, oxygen, nitrogen, sulfur and phosphorus, having a mass of 15 to 500 Daltons; T 3 is an organic moiety formed from carbon and one or more of hydrogen, fluoride, iodide, oxygen, nitrogen, sulfur and phosphorus, having a mass of 50 to 1000 Daltons; J is a direct bond or a functional group selected from amide, ester, amine, sulfide, ether, thioester, disulfide, thioether, urea, thiourea, carbamate, thiocarbamate, Schiff base, reduced Schiff base, imine, oxime, hydrazone, phosphate, phosphonate, phosphoramide, phosphonamide, sulfonate, sulfonamide or carbon-carbon bond; and p is an organic moiety formed
- R a has a formula comprising:
- G is (CH 2 ) ⁇ - 6 wherein a hydrogen on one and only one of the
- T 2 and T 4 are organic moieties of the formula C ⁇ -25 No- 9 ⁇ 0 - 9 So- 3 Po- H ⁇ F ⁇ I ⁇ wherein the sum of ⁇ , ⁇ and ⁇ is sufficient to satisfy the otherwise unsatisfied valencies of the C, N, O, S and P atoms;
- Amide is — N— C — or — C— N — ;
- R is hydrogen or C 0 alkyl;
- w is an
- the invention further provides a composition comprising compounds of formulae (1) and/or (II) wherein the formula (I):formula (II) molar ratio in the composition is within the range of 95:5 to 100:0 or within the range of 5:95 to 0: 100.
- the invention further provides a process for providing an enantiomerically-enriched compound comprising contacting a compound of the formula:
- Z is selected from oxygen, nitrogen and sulfur, where R 6 is hydrogen when Z is oxygen or sulfur, and when Z is nitrogen then R 6 is selected from hydrogen and -C 22 hydrocarbon and two R groups are bonded to Z;
- R 5 at each occurrence is independently either halogen or an organic moiety having a mass of less than 500 Daltons; m is selected from 0, 1, 2, 3 and 4;
- the compound to be acted upon in the process has the formula:
- R at each occurrence is independently either halogen or an organic moiety having a mass of less than 500 Daltons; m is selected from 0, 1, 2, 3 and 4; R is hydrogen or an organic moiety; and the compound is contacted with an enzyme to provide an enantiomerically-enriched compound of the formula:
- the compound to be acted upon in the process has the formula:
- the compound to be acted upon in the process has the formula:
- R 5 at each occurrence is independently either halogen or an organic moiety having a mass of less than 500 Daltons; m is selected from 0, 1 , 2, 3 and 4; R 7 is hydrogen or an organic moiety; and the compound is contacted with a chiral acid, to provide an enantiomerically-enriched salt of the formula:
- the compound to be acted upon in the process has the formula: wherein R ⁇ at each occurrence is independently either halogen or an organic moiety having a mass of less than 500 Daltons; m is selected from 0, 1 , 2, 3 and 4; and the compound is contacted with a chiral amine, to provide an enantiomerically enriched salt of the formula:
- the compound to be acted upon in the process has the formula:
- R at each occurrence is independently either halogen or an organic moiety having a mass of less than 500 Daltons; m is selected from 0, 1, 2, 3 and 4; and the compound is contacted with hydrogen in the presence of a chiral hydrogenation catalyst, to provide an enantiomerically-enriched compound of the formula:
- the invention provides compounds of the formula
- the invention provides compounds of the formula
- the phosphoramidite moiety of R 1 1 has the formula -O-P(OR 13 )(N(R l ) 2 ) wherein each of R 13 and R 14 is independently selected from an alkyl group or a substituted alkyl group having one or more substituents selected from halogen and cyano, and two R 14 groups may be bonded together to form a heterocycloalkyl group with the nitrogen of the phosphoramidite.
- the present invention provides tags suitable for coupling to nucleic acids or other molecules of interest.
- the tags When coupled to DNA, the tags provide a means to achieve a high- throughput genotyping system.
- the linker between the tag and the molecule of interest should completely cleave under conditions that do not cause tag fragmentation.
- the tag preferably yields one peak per oligonucleotide injected, and gives optimal signal in terms of ion current.
- the tag is preferably stable to PCR conditions, HPLC, and other manipulations used in assay formats. Reagents to introduce tags to a molecule of interest should proceed reproducibly and in good yield. In a preferred approach to meeting these objectives, a modular structure was developed that allows CMST components to be optimized independently.
- the components of a CMST preferably include a photolabile linker, a mass spectrometry sensitivity enhancer (MSSE), and a variable mass unit (VMU), all connected together through a scaffold.
- MSSE mass spectrometry sensitivity enhancer
- VMU variable mass unit
- the present invention provides tagged molecules of interest, precursors to tagged molecules of interest, and methods for generated the tagged molecules and precursors thereto, wherein the tag is enantiomerically-enriched. By using enantiomerically-enriched precursors, the purification of the reaction product of the precursor and the molecule of interest, in order to afford purified tagged molecule of interest, is facilitated.
- the present invention provides a compound having the formula (I) or (II):
- R is selected from halogen and organic moieties; R and R are independently selected from hydrogen and organic moieties having a mass greater than 15 Daltons where R " and R can together form a carbonyl group or may be joined together within a cyclic structure; Z is an (n+l)-valent atom excluding carbon where n is an integer greater than 0; R 4 is independently selected from hydrogen, halogen, and organic moieties having a mass greater than 15 Daltons, with the proviso that at least one R 4 is an organic moiety having a mass greater than 100 Daltons; R 5 at each occurrence is independently either halogen or an organic moiety having a mass of less than 500 Daltons; and m is selected from 0, 1, 2, 3 and 4.
- the compound of the invention is enantiomerically enriched, such that if compounds of both formulae (I) and (II) are present in an admixture, the molar formula (I): formula (II) ratio in the admixture is other than 50:50.
- the compound of the invention includes a 2-nitrophenyl group having, at the 1 -position of the phenyl ring, a substituted methyl group, where the carbon atom of the methyl group will be referred to herein as either Cl or the benzylic carbon atom.
- the C 1 atom is directly bonded to a hydrogen atom (not shown), a carbon atom (referred to herein as C2) and a non-carbon atom.
- compounds of the invention are photocleavable. That is, compounds of the invention will respond to contact with certain electromagnetic radiation by undergoing a cleavage reaction whereby the substituted Z atom separates from Cl as shown in the following structures, where indicates a bond that is photolytically unstable.
- C 1 is directly bonded to only one atom that is not a carbon or hydrogen atom
- compounds of the invention undergo a selective photocleavage reaction. That is, the Cl-Z bond can be selectively cleaved by appropriate photolytic conditions, leaving the other C 1 bonds largely if not entirely intact. This selective cleavage can occur so long as Z is not a carbon atom.
- Z is selected from oxygen, nitrogen and sulfur. Each of oxygen, nitrogen, and sulfur is a preferred atom for position Z.
- any one or more of the hydrogen atoms of the phenyl ring may be replaced with an equal number of R 5 groups.
- compounds of the invention may have a number ("m") of R 5 groups, where m is an integer selected from 0, 1, 2, 3 and 4.
- the desired photocleavage chemistry is largely independent of the nature of the R 5 group, so that R 5 may be an inorganic group, e.g., halogen, or an organic group. Typically, an organic R group is not too large, and accordingly has a mass of less than about 500 Daltons.
- Preferred R 5 groups are selected from C)-C 22 hydrocarbon groups.
- m is equal to zero, so that the 2-nitrophenyl ring has four hydrogen substituents.
- the resulting Z-containing residue which derived from a compound of the invention will be referred to herein as a tag.
- the tag is, or includes a detectable moiety, where this term refers to a moiety that can be detected, and preferably characterized, by an analytical method.
- Representative analytical methods include spectrometric or potentiometric methods.
- Representative spectrometric methods include mass spectrometry, infrared spectrometry, ultraviolet spectrometry and fluorescent spectrometry.
- a representative potentiometric method is potentiostatic amperometry.
- At least one R 4 group is an organic moiety having a mass greater than 100 Daltons.
- This R 4 group will be referred to herein as the first R 4 group (or R 4a ). That tags should have masses greater than 100 Daltons is desirable for a number of reasons. When the tags have masses of less than 100 Daltons, it may be difficult to identify the tags. For instance, where the tags are identified and characterized by mass spectrometry, tags of molecular weight less than 100 Daltons may be difficult to distinguish from the background noise inherent in the operation of a mass spectrometer.
- the present invention provides compositions containing a number of non-identical compounds of the invention, where the non-identical compounds contain non-identical tags that may be distinguished from one another by an analytical method.
- the tags In order to distinguish a number of non-identical tags, the tags must be sufficiently different from one another that the analytical method can detect the difference.
- the tags In order to obtain a suitable number of tags that are distinct by, e.g., potentiometry, the tags must contain a number of atoms that can be bonded together in non-identical ways which are analytically distinct.
- tags have a mass of less than 100 Daltons, there are an unduly limiting number of analytically distinct tags. Accordingly, to allow sufficient variability in structure, and to allow easy and effective detection, the tags should have masses in excess of 100 Daltons.
- the identity of the other R 4 groups in a compound of the invention may be selected to achieve one or more goals.
- a second or more R 4 (e.g., R 4b , R 4c , etc.) group may impart information supplementing the information derived from the first R 4 group.
- a second or more R 4 group also preferably has a mass of at least 100 Daltons.
- the second or more R 4 groups do no more than satisfy the otherwise unsatisfied valence state of Cl , not interfere with the photocleavage reaction or detection of the tag, and be synthetically easy to form.
- the second or more R 4 groups might be hydrogen or simple hydrocarbon groups.
- the second or more R 4 groups, if present, is/are hydrogen.
- R 1 is selected from halogen and organic moieties, while R and R are independently selected from hydrogen and organic moieties having a mass greater than 15 Daltons.
- compounds of the invention include a detectable moiety where detection, and optionally characterization of the detectable moiety provides information about the compound of the invention.
- the R 1 group contains the feature of the compound about which information is desired.
- R 1 may include biological material from an individual, and the tag is characteristic of that individual and/or the specific biological material.
- the R group may contain a particular synthetic nucleic acid, peptide or saccharide sequence, which is uniquely identified by the tag.
- R 1 is a reactive chemical group which can undergo a chemical reaction whereby biologically-derived material may be photocleavably linked to a tag.
- R 1 may be a halogen atom which may be displaced in a chemical reaction by biological material or derivatized biological material.
- the R 2 and R groups are independently selected from hydrogen and organic moieties having a mass greater than 15 Daltons. Typically, the R 2 and R 3 groups are selected with a view to their impact on the chemistry selected for joining R 1 to Cl, and/or for their impact on the photocleavage reaction whereby the tag is separated from C 1. When each of R 2 and R 3 is hydrogen, then neither R 2 nor R 3 adversely impacts the photocleavage reaction, and typically they are compatible with
- R and R are preferably
- R and R could be groups other than hydrogen.
- R and R together might form a carbonyl group with C 1.
- R and R might, together with C 1 , form a cyclic structure.
- either of R 2 or R 3 might be an organic moiety of mass greater than 15 Daltons, e.g., a C]-C 22 hydrocarbon group.
- hydrocarbon groups do not interfere with the desired photocleavage reaction, and do not interfere with R C I coupling chemistry.
- Another feature of a compound of the invention is that the Cl atom is chiral. As seen from the formulae (I) and (II), the nature of the substituents on Cl necessarily require that Cl is chiral. In addition, if compounds of formulae (I) and (II) are in admixture, the molar ratio of the formula (I) compounds to the formula (II) compounds is other than 50:50. In a preferred embodiment of the invention, compounds of formula (I) are not in admixture with compounds of formula (II), and vice versa.
- the molar ratio of the formula (I) compounds to the formula (II) compounds is preferably in excess of 95:5, or 96:4, or 97:3, or 98:2, or 99:1, or in excess of 99.5:0.5, or vice versa (i.e., the molar ratio of the formula (II) compounds to the formula (I) compounds is preferably in excess of 95:5, or 96:4, or 97:3, or 98:2, or 99: 1, or in excess of 99.5:0.5).
- compositions containing a plurality of compounds of formulae (I) or (II) which, because of their isomeric constitution, may be more readily separated from one another than would otherwise be the case. This enhanced ability to distinguish differently tagged compounds allows the formation of compositions that could otherwise not be characterized.
- the present invention addresses this problem by providing compounds of formula (I) free of, or effectively free of, compounds of formula (II).
- the present invention is directed to a process for providing an enantiomerically-enriched compound using a specified agent. More specifically, the process acts on a compound of the formula:
- Z is selected from oxygen, nitrogen and sulfur; where R 6 is hydrogen when Z is oxygen or sulfur, and when Z is nitrogen then R 6 is selected from hydrogen and C t -C 2 hydrocarbon and two R 6 groups are bonded to Z; R 5 at each occurrence is independently either halogen or an organic moiety having a mass of less than 500 Daltons; m is selected from 0, 1, 2, 3 and 4; R 7 is hydrogen or an organic moiety, and the bond represented by both a solid and dashed line represents either a single or double bond.
- the inventive process contacts a compound as identified above with an agent.
- the compound is contacted with the agent so as to provide an enantiomerically-enriched compound of the formula:
- Molecules with photocleavably attached tags which may be provided in optically-enriched form according to the present invention, as well as methods that may be practiced with compounds and compositions of the present invention, are set forth in, for example, PCT International Publication Nos. WO 99/05319; WO 97/27331 ; WO 97/27327; WO 97/27325; and WO 95/04160.
- the compounds of the present invention may be substituted for the tagged compounds disclosed in these four publications, as well as other methods and assays where molecules having photocleavably linked tags are utilized.
- the following examples are set forth as a means of illustrating the present invention and are not to be construed as a limitation thereon.
- the chemical reactants and reagents were of standard commercial grade, obtained from commercial supply houses such as Aldrich (Milwaukee, WI; www.sigma-aldrich.com), Fluka (a division of Aldrich) and Lancaster Synthesis, Inc. (Windham, NH; http://www.lancaster.co.uk).
- the initial filtrate was basified to pH 8 and extracted first with the DCM washings collected above; and secondly with fresh DCM.
- the organic layers were combined, dried and evaporated to give the amino ethyl ester (23 g, 80%o yield).
- the enantiomeric excess (e.e.) of both the amino acid and amino ethyl ester were determined by cHPLC and were both in excess of 98% enantiomerically pure.
- the tags described herein are preferably conjugated to a molecule of interest through a photolabile bond.
- a preferred photolabile bond is present within an o-nitrobenzyl group (see, e.g., (a) Greenberg, M.M.; Gilmore, J.L. J. Org. Chem. 1994, 59, 746-753; (b) Yoo, D.J.; Greenberg, M.M. J. Org. Chem. 1995, 60, 3358-3364; and (c) Venkatesan, H.; Greenberg, M.M. J. Org. Chem. 1996, 61, 525-529).
- the intramolecular photoredox reaction in an o-nitrobenzyl group (see, e.g., Pillai, V.N.R. Synthesis 1980, 1-26) enables the tag to cleave from the oligonucleotide quickly under neutral conditions (six second exposure with a 254nm Hg lamp) and with no fragmentation.
- the synthetic route begins (Scheme 1) with esterification of the photosensitive linker 3-amino-3-(2-nitrophenyl) propionic acid, (ANP, 1, see, e.g., Brown, B.B.; Wagner, D.S.; Geysen, H.M. Molecular Diversity 1995, 1, 4-12; and (b) Rodebaugh, R.; Fraser-Reid, B.; Geysen, H.M. Tetrahedron Letters 1997, 38, 7653- 7656) to give the ethyl ester hydrochloride (2) in 84%> yield.
- ABP 1, see, e.g., Brown, B.B.; Wagner, D.S.; Geysen, H.M. Molecular Diversity 1995, 1, 4-12; and (b) Rodebaugh, R.; Fraser-Reid, B.; Geysen, H.M. Tetrahedron Letters 1997, 38, 7653- 7656
- Lysine provided a very suitable scaffold for the modular approach to the synthesis of the tags.
- the two amine and one carboxylic acid groups present in lysine provided handles for robust peptide chemistries with resulting amide linkages between the tag components.
- Peptides have a predictable behavior in mass spectrometry and are also relatively stable to 254 nm light.
- Perfluorinated aromatics may be used as electrophoric labels for analytical purposes in negative ion mode mass spectrometry (see, e.g., (a) Abdel-Baky, S.; Klempier, N.; Giese, R.W. Tetrahedron 1990, 46, 5859; (b) Abdel-Baky, S.; Allam, K.; Giese, R.W. Anal. Chem. 1993, 65, 498-499; (c) Trainor, T; Giese, R.W.; Vouros, P. Journal of Chromatography 1988, 452, 369-376; and (d) Saha, M.; Saha, J.; Giese, R.W.
- INA hydrochloride was coupled to 7, using EDAC and triethylamine, to give crude Alloc-protected structure 8, which was deprotected with diethylamine, triphenylphosphine, and palladium acetate.
- the resulting core structure (9) was crystallized from the reaction mixture and recovered by filtration in 95% yield as a yellow solid.
- VMUs variable mass units
- the masses of the VMUs are spaced a minimum of 4 a.m.u. apart, to minimize isotopic overlap between tags.
- the molecular weights of the VMUs ranged from 90-298 a.m.u.
- VMUs did not have the following properties or features: (1) functionalities incompatible with the synthetic sequence, such as esters; (2) elements with multiple isotopes (Cl, Br, S); (3) functionalities that might lead to competing photoprocesses (iodides, acyl- and aryl-phenones); (4) racemic acids, and (5) lack of commercial availability.
- VMUs were coupled to 9, using HATU and N-methyl mo ⁇ holine. After purification by column chromatography, the CMST ethyl ester (10) was recovered in variable yields. Saponification of 10 with NaOH gave the CMST acid (11) in quantitative yield.
- TFP TFA tetrafluorophenyl trifluoroacetate
- the tetrafluorophenyl active ester was chosen because of easily removed side products and relative stability and compatibility towards oligonucleotide conjugation conditions.
- the CMST TFP esters were conjugated to 5'-aminohexyl-tailed oligonucleotides (obtained from TriLink Biotechnology, San Diego, CA) according to the method of Lukhtanov et al. (see, e.g., Lukhtanov, E.A.; Kutyavin, I.V.; Gamper, H.B.; Meyer, R.B. Jr. Bioconjug. Chem. 1995, 4, 418-426).
- the number of tags was further expanded by the incremental use of a tyrosine derivative which functioned as a gross mass adjuster (GMA, and more specifically N-Boc-O-ethyl-L-tyrosine, which can be ordered commercially from Bachem California (Torrance, CA) or prepared by alkylation of N-Boc-L-Tyrosine-OMe with iodoethane and cesium carbonate in 86%o yield, followed by hydrolysis with NaOH in quantitative) which increases the molecular weight of the cleaved tag by 191 a.m.u. and allows the set of VMUs to be re-used for higher molecular weight tags.
- GMA gross mass adjuster
- the VMUs were coupled in the same manner as before, resulting in additional sets of tags (14). Using four units of the mass adjuster, a total of nearly 200 tags may be synthesized.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00961549A EP1208079A1 (en) | 1999-08-31 | 2000-08-31 | Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto |
JP2001519660A JP2003508378A (ja) | 1999-08-31 | 2000-08-31 | 光切断性結合を有するエナンチオマーに富む化合物およびそれに関連する方法 |
AU73490/00A AU7349000A (en) | 1999-08-31 | 2000-08-31 | Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto |
CA002384191A CA2384191A1 (en) | 1999-08-31 | 2000-08-31 | Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto |
MXPA02002265A MXPA02002265A (es) | 1999-08-31 | 2000-08-31 | Compuestos enatiomericamente enriquecidos que tienen enlace (s) fotodesdoblable (s) y metodos relacionados a los mismos. |
BR0013024-9A BR0013024A (pt) | 1999-08-31 | 2000-08-31 | Comtostos enantiomiericamente enriquecidos tendo ligação( ões ) fotoclivável( is ) e métodos relacionados aos mesmos |
KR1020027002645A KR20020037042A (ko) | 1999-08-31 | 2000-08-31 | 광절단가능한 결합(들)을 갖는 에난티오머적으로-농축된화합물 및 이와 관련된 방법 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15176999P | 1999-08-31 | 1999-08-31 | |
US60/151,769 | 1999-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001016090A1 true WO2001016090A1 (en) | 2001-03-08 |
Family
ID=22540173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/024347 WO2001016090A1 (en) | 1999-08-31 | 2000-08-31 | Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1208079A1 (es) |
JP (1) | JP2003508378A (es) |
KR (1) | KR20020037042A (es) |
CN (1) | CN1371356A (es) |
AU (1) | AU7349000A (es) |
BR (1) | BR0013024A (es) |
CA (1) | CA2384191A1 (es) |
MX (1) | MXPA02002265A (es) |
WO (1) | WO2001016090A1 (es) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1361279A1 (de) * | 2002-05-08 | 2003-11-12 | Degussa AG | Verfahren zur enzymatischen Herstellung enantiomerenangereicherter beta-Aminosäuren |
US6869781B2 (en) | 2002-05-08 | 2005-03-22 | Degussa Ag | Process for the enzymatic preparation of enantiomer-enriched β-amino acids |
RU2494090C2 (ru) * | 2008-07-23 | 2013-09-27 | Цзянсу Хэнжуй Медицин Ко., Лтд. | Способ получения производных r-бета-аминофенилмасляной кислоты |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997027325A2 (en) * | 1996-01-23 | 1997-07-31 | Rapigene, Inc. | Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
WO1997027331A2 (en) * | 1996-01-23 | 1997-07-31 | Rapigene, Inc. | Methods and compositions for determining the sequence of nucleic acid molecules |
WO1997027327A2 (en) * | 1996-01-23 | 1997-07-31 | Rapigene, Inc. | Methods and compositions for detecting binding of ligand pair using non-fluorescent label |
WO1999005319A2 (en) * | 1997-07-22 | 1999-02-04 | Rapigene, Inc. | Methods and compounds for analyzing nucleic acids by mass spectrometry |
-
2000
- 2000-08-31 KR KR1020027002645A patent/KR20020037042A/ko not_active Application Discontinuation
- 2000-08-31 CN CN00812153A patent/CN1371356A/zh active Pending
- 2000-08-31 BR BR0013024-9A patent/BR0013024A/pt not_active Application Discontinuation
- 2000-08-31 MX MXPA02002265A patent/MXPA02002265A/es unknown
- 2000-08-31 WO PCT/US2000/024347 patent/WO2001016090A1/en not_active Application Discontinuation
- 2000-08-31 CA CA002384191A patent/CA2384191A1/en not_active Abandoned
- 2000-08-31 JP JP2001519660A patent/JP2003508378A/ja not_active Withdrawn
- 2000-08-31 AU AU73490/00A patent/AU7349000A/en not_active Abandoned
- 2000-08-31 EP EP00961549A patent/EP1208079A1/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997027325A2 (en) * | 1996-01-23 | 1997-07-31 | Rapigene, Inc. | Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
WO1997027331A2 (en) * | 1996-01-23 | 1997-07-31 | Rapigene, Inc. | Methods and compositions for determining the sequence of nucleic acid molecules |
WO1997027327A2 (en) * | 1996-01-23 | 1997-07-31 | Rapigene, Inc. | Methods and compositions for detecting binding of ligand pair using non-fluorescent label |
WO1999005319A2 (en) * | 1997-07-22 | 1999-02-04 | Rapigene, Inc. | Methods and compounds for analyzing nucleic acids by mass spectrometry |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1361279A1 (de) * | 2002-05-08 | 2003-11-12 | Degussa AG | Verfahren zur enzymatischen Herstellung enantiomerenangereicherter beta-Aminosäuren |
US6869781B2 (en) | 2002-05-08 | 2005-03-22 | Degussa Ag | Process for the enzymatic preparation of enantiomer-enriched β-amino acids |
US6987010B2 (en) | 2002-05-08 | 2006-01-17 | Degussa Ag | Process for the enzymatic preparation of enantiomer-enriched β-amino acids |
RU2494090C2 (ru) * | 2008-07-23 | 2013-09-27 | Цзянсу Хэнжуй Медицин Ко., Лтд. | Способ получения производных r-бета-аминофенилмасляной кислоты |
Also Published As
Publication number | Publication date |
---|---|
CN1371356A (zh) | 2002-09-25 |
JP2003508378A (ja) | 2003-03-04 |
KR20020037042A (ko) | 2002-05-17 |
AU7349000A (en) | 2001-03-26 |
CA2384191A1 (en) | 2001-03-08 |
EP1208079A1 (en) | 2002-05-29 |
BR0013024A (pt) | 2002-06-18 |
MXPA02002265A (es) | 2003-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1095053B1 (en) | Arylsulfone linkers for mass spectrometric analysis | |
EP1200628A2 (en) | Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids | |
JP2002503456A (ja) | Pnaおよびdna複合体およびその調製方法 | |
EP1208079A1 (en) | Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto | |
US20080138817A1 (en) | Novel Functional Peptide Nucleic Acid Monomer and Process for Producing the Same | |
US6372885B1 (en) | Solid-phase technology for the preparation of amides | |
US7164014B2 (en) | Protected linker compounds | |
US6528684B1 (en) | Synthesis of (R) and (S) -aminocarnitine and their derivatives starting from D- and L-aspartic acid | |
Tsushima et al. | Fluorine-containing amino acids and their derivatives. 9. Synthesis and biological activities of difluoromethylhomocysteine | |
EP1308452B1 (en) | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | |
US7772439B2 (en) | Amino or thiol linker building block for the synthesis of amino- or thiol-functionalized nucleic acids and methods of making and use thereof | |
JPH0558629B2 (es) | ||
US20030153784A1 (en) | Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid | |
EP2192110B1 (en) | Method of producing optically active n-(halopropyl)amino acid derivative | |
US5929242A (en) | Manufacture of levobupivacaine and analogues thereof from L-lysine | |
US20040249152A1 (en) | Method for the production of cna | |
EP0734453A1 (en) | Phenylserine amides and the preparation of phenylserines/phenylserine amides | |
US7687618B2 (en) | Method of manufacturing labelled oligonucleotide conjugates | |
US20030153783A1 (en) | Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid | |
Zheng | C1'oxidative DNA damage and hydrophobic DNA interactions | |
Bhatia | Solid-‐Phase Biotinylation of Oligodeoxynucleotides Without Use of Biotin Phosphoramidite Reagent. | |
JPH085812B2 (ja) | 酸アミド化合物の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 73490/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 516623 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000961549 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020027002645 Country of ref document: KR Ref document number: 008121532 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/002265 Country of ref document: MX Ref document number: 2384191 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027002645 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2000961549 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000961549 Country of ref document: EP |